SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-17-048043
Filing Date
2017-07-31
Accepted
2017-07-31 16:02:17
Documents
3
Period of Report
2017-07-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a17-18591_18k.htm 8-K 25160
2 EX-99.1 a17-18591_1ex99d1.htm EX-99.1 11150
3 GRAPHIC g185911mmi001.jpg GRAPHIC 9490
  Complete submission text file 0001104659-17-048043.txt   50704
Mailing Address 281 TRESSER BOULEVARD, 9TH FLOOR STAMFORD CT 06901
Business Address 281 TRESSER BOULEVARD, 9TH FLOOR STAMFORD CT 06901 203-653-3880
Loxo Oncology, Inc. (Filer) CIK: 0001581720 (see all company filings)

IRS No.: 462996673 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36562 | Film No.: 17992982
SIC: 2834 Pharmaceutical Preparations